$OHI
OMEGA HEALTHCARE INVESTORS INC

2023 Q2 Form 10-Q Financial Statement

#000088849123000015 Filed on May 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $250.2M $218.2M
YoY Change 2.26% -12.48%
Cost Of Revenue $3.925M $3.997M
YoY Change 5.6% 10.94%
Gross Profit $246.3M $214.2M
YoY Change 2.21% -12.82%
Gross Profit Margin 98.43% 98.17%
Selling, General & Admin $35.13M $16.47M
YoY Change 104.07% -9.56%
% of Gross Profit 14.26% 7.69%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $82.02M $81.19M
YoY Change -1.43% -1.89%
% of Gross Profit 33.31% 37.9%
Operating Expenses $117.1M $199.8M
YoY Change -32.74% 19.14%
Operating Profit $129.1M $14.37M
YoY Change 93.38% -81.57%
Interest Expense -$58.78M -$58.55M
YoY Change 0.69% 0.69%
% of Operating Profit -45.52% -407.3%
Other Income/Expense, Net $1.029M $16.35M
YoY Change -95.04% -85.55%
Pretax Income $62.08M $34.72M
YoY Change -31.97% -82.17%
Income Tax $1.626M -$1.292M
% Of Pretax Income 2.62% -3.72%
Net Earnings $59.86M $36.85M
YoY Change -34.88% -81.12%
Net Earnings / Revenue 23.92% 16.89%
Basic Earnings Per Share $0.25 $0.15
Diluted Earnings Per Share $0.25 $0.15
COMMON SHARES
Basic Shares Outstanding 234.4M 234.3M
Diluted Shares Outstanding 246.1M 243.2M

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $350.7M $245.2M
YoY Change 112.61% -50.09%
Cash & Equivalents $350.7M $245.2M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $8.837M $7.999M
Other Receivables $200.7M $190.8M
Total Short-Term Assets $560.2M $444.0M
YoY Change 25.79% -42.66%
LONG-TERM ASSETS
Property, Plant & Equipment $6.489B $6.438B
YoY Change -2.92% -5.28%
Goodwill $643.9M $643.5M
YoY Change -0.94% -1.16%
Intangibles
YoY Change
Long-Term Investments $200.7M $181.3M
YoY Change 9.23% -5.67%
Other Assets $7.220M $29.10M
YoY Change -88.92% -69.78%
Total Long-Term Assets $8.844B $8.846B
YoY Change -2.56% -4.26%
TOTAL ASSETS
Total Short-Term Assets $560.2M $444.0M
Total Long-Term Assets $8.844B $8.846B
Total Assets $9.404B $9.290B
YoY Change -1.23% -7.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $289.6M $301.0M
YoY Change 18.97% 30.65%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $289.6M $301.0M
YoY Change 18.97% 30.65%
LONG-TERM LIABILITIES
Long-Term Debt $5.287B $5.288B
YoY Change -0.47% -6.05%
Other Long-Term Liabilities $15.00M $15.67M
YoY Change -40.01% -39.75%
Total Long-Term Liabilities $5.302B $5.304B
YoY Change -0.66% -6.2%
TOTAL LIABILITIES
Total Short-Term Liabilities $289.6M $301.0M
Total Long-Term Liabilities $5.302B $5.304B
Total Liabilities $5.780B $5.605B
YoY Change 3.57% -4.76%
SHAREHOLDERS EQUITY
Retained Earnings $3.534B $3.474B
YoY Change 7.4% 8.54%
Common Stock $24.10M $23.43M
YoY Change 2.94% -1.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.624B $3.497B
YoY Change
Total Liabilities & Shareholders Equity $9.404B $9.290B
YoY Change -1.23% -7.23%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $59.86M $36.85M
YoY Change -34.88% -81.12%
Depreciation, Depletion And Amortization $82.02M $81.19M
YoY Change -1.43% -1.89%
Cash From Operating Activities $170.4M $111.4M
YoY Change -1.51% -15.77%
INVESTING ACTIVITIES
Capital Expenditures $138.4M $31.16M
YoY Change -4267.52% -126.45%
Acquisitions
YoY Change
Other Investing Activities -$48.88M $33.82M
YoY Change -147.39% -88.54%
Cash From Investing Activities -$187.3M $2.657M
YoY Change -287.65% -98.5%
FINANCING ACTIVITIES
Cash Dividend Paid $157.4M
YoY Change -2.03%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $1.913M
YoY Change -97.14%
Cash From Financing Activities 124.7M -166.4M
YoY Change -120.86% -203.22%
NET CHANGE
Cash From Operating Activities 170.4M 111.4M
Cash From Investing Activities -187.3M 2.657M
Cash From Financing Activities 124.7M -166.4M
Net Change In Cash 107.8M -52.13M
YoY Change -133.15% -111.08%
FREE CASH FLOW
Cash From Operating Activities $170.4M $111.4M
Capital Expenditures $138.4M $31.16M
Free Cash Flow $31.93M $80.20M
YoY Change -81.89% -67.92%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-407000
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
5895000
CY2023Q1 ohi Deferred Tax Liabilities Foreign Basis And Timing Differences
DeferredTaxLiabilitiesForeignBasisAndTimingDifferences
1818000
CY2023Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1818000
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000888491
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q1 ohi Total Gross Write Off Of Receivable Year One Originated Current Fiscal Year
TotalGrossWriteOffOfReceivableYearOneOriginatedCurrentFiscalYear
CY2023Q1 ohi Total Gross Write Off Of Receivable Year Two Originated Current Fiscal Year
TotalGrossWriteOffOfReceivableYearTwoOriginatedCurrentFiscalYear
CY2023Q1 ohi Total Gross Write Off Of Receivable Year Three Originated Current Fiscal Year
TotalGrossWriteOffOfReceivableYearThreeOriginatedCurrentFiscalYear
CY2023Q1 ohi Total Gross Write Off Of Receivable Year Four Originated Current Fiscal Year
TotalGrossWriteOffOfReceivableYearFourOriginatedCurrentFiscalYear
CY2023Q1 ohi Total Gross Write Off Of Receivable Year Five Originated Current Fiscal Year
TotalGrossWriteOffOfReceivableYearFiveOriginatedCurrentFiscalYear
CY2023Q1 ohi Total Gross Write Off Of Receivable Year Six Originated Current Fiscal Year
TotalGrossWriteOffOfReceivableYearSixOriginatedCurrentFiscalYear
CY2023Q1 ohi Total Gross Write Off Of Receivable Year Six Or More Years Before Latest Fiscal Year
TotalGrossWriteOffOfReceivableYearSixOrMoreYearsBeforeLatestFiscalYear
CY2023Q1 ohi Total Gross Write Off Of Receivable Revolving
TotalGrossWriteOffOfReceivableRevolving
CY2023Q1 ohi Total Gross Write Off Of Receivable Total
TotalGrossWriteOffOfReceivableTotal
CY2023Q1 us-gaap Financing Receivable Practical Expedient Accrued Interest Exclusion
FinancingReceivablePracticalExpedientAccruedInterestExclusion
true
CY2023Q1 ohi Minimum Number Of Subsequent Years Company May Not Be Able To Qualify As Areit
MinimumNumberOfSubsequentYearsCompanyMayNotBeAbleToQualifyAsAreit
P4Y
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
OMEGA HEALTHCARE INVESTORS, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2023Q1 dei Entity File Number
EntityFileNumber
1-11316
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
38-3041398
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
303 International Circle, Suite 200
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Hunt Valley
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
21030
CY2023Q1 dei City Area Code
CityAreaCode
410
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
427-1700
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock
CY2023Q1 dei Trading Symbol
TradingSymbol
OHI
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
234353375
CY2023Q1 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
7303014000
CY2022Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
7347853000
CY2023Q1 us-gaap Land
Land
926180000
CY2022Q4 us-gaap Land
Land
923605000
CY2023Q1 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
498334000
CY2022Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
499902000
CY2023Q1 us-gaap Development In Process
DevelopmentInProcess
94698000
CY2022Q4 us-gaap Development In Process
DevelopmentInProcess
88904000
CY2023Q1 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
8822226000
CY2022Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
8860264000
CY2023Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
2384191000
CY2022Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
2322773000
CY2023Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
6438035000
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
6537491000
CY2023Q1 us-gaap Direct Financing Lease Net Investment In Lease Excluding Accrued Interest After Allowance For Credit Loss
DirectFinancingLeaseNetInvestmentInLeaseExcludingAccruedInterestAfterAllowanceForCreditLoss
8670000
CY2022Q4 us-gaap Direct Financing Lease Net Investment In Lease Excluding Accrued Interest After Allowance For Credit Loss
DirectFinancingLeaseNetInvestmentInLeaseExcludingAccruedInterestAfterAllowanceForCreditLoss
8503000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
1061869000
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
1042731000
CY2023Q1 us-gaap Equity Method Investments
EquityMethodInvestments
181339000
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
178920000
CY2023Q1 us-gaap Real Estate Heldforsale
RealEstateHeldforsale
25766000
CY2022Q4 us-gaap Real Estate Heldforsale
RealEstateHeldforsale
9456000
CY2023Q1 ohi Total Real Estate Investments
TotalRealEstateInvestments
7715679000
CY2022Q4 ohi Total Real Estate Investments
TotalRealEstateInvestments
7777101000
CY2023Q1 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
189880000
CY2022Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
225281000
CY2023Q1 us-gaap Investments
Investments
7905559000
CY2022Q4 us-gaap Investments
Investments
8002382000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
245182000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
297103000
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3336000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3541000
CY2023Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
7999000
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
8228000
CY2023Q1 us-gaap Other Receivables
OtherReceivables
190842000
CY2022Q4 us-gaap Other Receivables
OtherReceivables
177798000
CY2023Q1 us-gaap Goodwill
Goodwill
643500000
CY2022Q4 us-gaap Goodwill
Goodwill
643151000
CY2023Q1 us-gaap Other Assets
OtherAssets
293788000
CY2022Q4 us-gaap Other Assets
OtherAssets
272960000
CY2023Q1 us-gaap Assets
Assets
9290206000
CY2022Q4 us-gaap Assets
Assets
9405163000
CY2023Q1 us-gaap Line Of Credit
LineOfCredit
19784000
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
19246000
CY2023Q1 us-gaap Secured Debt
SecuredDebt
364773000
CY2022Q4 us-gaap Secured Debt
SecuredDebt
366596000
CY2023Q1 ohi Senior Notes And Other Unsecured Borrowings Net
SeniorNotesAndOtherUnsecuredBorrowingsNet
4903377000
CY2022Q4 ohi Senior Notes And Other Unsecured Borrowings Net
SeniorNotesAndOtherUnsecuredBorrowingsNet
4900992000
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
316661000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
315047000
CY2023Q1 us-gaap Liabilities
Liabilities
5604595000
CY2022Q4 us-gaap Liabilities
Liabilities
5601881000
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
234346000
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
234346000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
234252000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
234252000
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
23434000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
23425000
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6322160000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6314203000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3474343000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3438401000
CY2023Q1 us-gaap Cumulative Dividends
CumulativeDividends
6344413000
CY2022Q4 us-gaap Cumulative Dividends
CumulativeDividends
6186986000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
21533000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
20325000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
3497057000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3609368000
CY2023Q1 us-gaap Minority Interest
MinorityInterest
188554000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
193914000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3685611000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3803282000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9290206000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9405163000
CY2023Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
189077000
CY2022Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
216883000
CY2023Q1 us-gaap Direct Financing Lease Revenue
DirectFinancingLeaseRevenue
254000
CY2022Q1 us-gaap Direct Financing Lease Revenue
DirectFinancingLeaseRevenue
256000
CY2023Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
28420000
CY2022Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
31143000
CY2023Q1 us-gaap Other Operating Income
OtherOperatingIncome
451000
CY2022Q1 us-gaap Other Operating Income
OtherOperatingIncome
1033000
CY2023Q1 us-gaap Revenues
Revenues
218202000
CY2022Q1 us-gaap Revenues
Revenues
249315000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
81192000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
82752000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20526000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16385000
CY2023Q1 us-gaap Real Estate Tax Expense
RealEstateTaxExpense
3997000
CY2022Q1 us-gaap Real Estate Tax Expense
RealEstateTaxExpense
3603000
CY2023Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
639000
CY2022Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1513000
CY2023Q1 ohi Impairment Recovery Of Real Estate Net
ImpairmentRecoveryOfRealEstateNet
38988000
CY2022Q1 ohi Impairment Recovery Of Real Estate Net
ImpairmentRecoveryOfRealEstateNet
3511000
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-4057000
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1824000
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
58546000
CY2022Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
58145000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
199831000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
167733000
CY2023Q1 ohi Investment Income Expense
InvestmentIncomeExpense
2720000
CY2022Q1 ohi Investment Income Expense
InvestmentIncomeExpense
-455000
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-6000
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-6000
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
13637000
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
113637000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
16351000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
113176000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
34722000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
194758000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1292000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1225000
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
831000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1623000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
36845000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
195156000
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
903000
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
5549000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
35942000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
189607000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.79
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.79
CY2023Q1 us-gaap Profit Loss
ProfitLoss
36845000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
195156000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
10793000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-10809000
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-9550000
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
19578000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1243000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8769000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
38088000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
203925000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
938000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
5800000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
37150000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
198125000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3803282000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8792000
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1985000
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.67
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
157427000
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
9131000
CY2023Q1 ohi Noncontrolling Interest Increase From Capital Contribution
NoncontrollingInterestIncreaseFromCapitalContribution
22000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1243000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
36845000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3685611000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4108226000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6905000
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1147000
CY2022Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
27321000
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.67
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
160687000
CY2022Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
5276000
CY2022Q1 ohi Noncontrolling Interest Increase From Capital Contribution
NoncontrollingInterestIncreaseFromCapitalContribution
2925000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8769000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
195156000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4129844000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
36845000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
195156000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
81192000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
82752000
CY2023Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
38988000
CY2022Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
3511000
CY2023Q1 ohi Provision For Rental Income
ProvisionForRentalIncome
12500000
CY2022Q1 ohi Provision For Rental Income
ProvisionForRentalIncome
3151000
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-4057000
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1824000
CY2023Q1 ohi Amortization Of Deferred Financing And Refinancing Costs
AmortizationOfDeferredFinancingAndRefinancingCosts
3259000
CY2022Q1 ohi Amortization Of Deferred Financing And Refinancing Costs
AmortizationOfDeferredFinancingAndRefinancingCosts
3199000
CY2023Q1 ohi Accretion Of Direct Financing Lease
AccretionOfDirectFinancingLease
-26000
CY2022Q1 ohi Accretion Of Direct Financing Lease
AccretionOfDirectFinancingLease
-19000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
8744000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6860000
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
13637000
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
113637000
CY2023Q1 us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
-6131000
CY2022Q1 us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
-1608000
CY2023Q1 ohi Increase Decrease In Straight Line Rent And Effective Interest Receivable
IncreaseDecreaseInStraightLineRentAndEffectiveInterestReceivable
12576000
CY2022Q1 ohi Increase Decrease In Straight Line Rent And Effective Interest Receivable
IncreaseDecreaseInStraightLineRentAndEffectiveInterestReceivable
23674000
CY2023Q1 ohi Interest Paid In Kind Operating Activities
InterestPaidInKindOperatingActivities
-2555000
CY2022Q1 ohi Interest Paid In Kind Operating Activities
InterestPaidInKindOperatingActivities
-2196000
CY2023Q1 ohi Gain Loss In Equity Method Investment Operating Activities
GainLossInEquityMethodInvestmentOperatingActivities
137000
CY2022Q1 ohi Gain Loss In Equity Method Investment Operating Activities
GainLossInEquityMethodInvestmentOperatingActivities
-677000
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-180000
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
1912000
CY2023Q1 ohi Increase Decrease In Lease Inducement
IncreaseDecreaseInLeaseInducement
12323000
CY2022Q1 ohi Increase Decrease In Lease Inducement
IncreaseDecreaseInLeaseInducement
-1932000
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
19232000
CY2022Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
22498000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
111360000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
132202000
CY2023Q1 us-gaap Payments To Acquire Commercial Real Estate
PaymentsToAcquireCommercialRealEstate
26383000
CY2022Q1 us-gaap Payments To Acquire Commercial Real Estate
PaymentsToAcquireCommercialRealEstate
113157000
CY2023Q1 us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
17559000
CY2022Q1 us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
332552000
CY2023Q1 us-gaap Payments For Construction In Process
PaymentsForConstructionInProcess
4780000
CY2022Q1 us-gaap Payments For Construction In Process
PaymentsForConstructionInProcess
4667000
CY2023Q1 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
31240000
CY2022Q1 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
103026000
CY2023Q1 us-gaap Proceeds From Collection Of Loans Receivable
ProceedsFromCollectionOfLoansReceivable
52011000
CY2022Q1 us-gaap Proceeds From Collection Of Loans Receivable
ProceedsFromCollectionOfLoansReceivable
79101000
CY2023Q1 us-gaap Proceeds From Divestiture Of Interest In Joint Venture
ProceedsFromDivestitureOfInterestInJointVenture
382000
CY2022Q1 us-gaap Proceeds From Divestiture Of Interest In Joint Venture
ProceedsFromDivestitureOfInterestInJointVenture
61000
CY2023Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
5340000
CY2022Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
13548000
CY2023Q1 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
448000
CY2022Q1 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
22000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2657000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
177338000
CY2022Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
420208000
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1913000
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
66896000
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
6000
CY2022Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
6000
CY2023Q1 ohi Net Proceeds From Issuance Of Common Stock
NetProceedsFromIssuanceOfCommonStock
1985000
CY2022Q1 ohi Net Proceeds From Issuance Of Common Stock
NetProceedsFromIssuanceOfCommonStock
1147000
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
27321000
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
157379000
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
160641000
CY2023Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
22000
CY2022Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
22000
CY2023Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
9131000
CY2022Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
5276000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-166422000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
161237000
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
279000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-52126000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
470370000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
300644000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24411000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
248518000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
494781000
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2023Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-style:normal;font-weight:bold;">Reclassification</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Certain line items on our Consolidated Statements of Operations and Consolidated Statements of Cash Flows have been reclassified to conform to the current period presentation.</p>
CY2023Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
185327000
CY2022Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
213597000
CY2023Q1 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
3750000
CY2022Q1 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
3286000
CY2023Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
189077000
CY2022Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
216883000
CY2023Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
26400000
CY2023Q1 ohi Payments For Capital Improvements And Construction In Progess
PaymentsForCapitalImprovementsAndConstructionInProgess
10100000
CY2022Q1 ohi Payments For Capital Improvements And Construction In Progess
PaymentsForCapitalImprovementsAndConstructionInProgess
18200000
CY2023Q1 us-gaap Real Estate Heldforsale
RealEstateHeldforsale
25766000
CY2022Q4 us-gaap Real Estate Heldforsale
RealEstateHeldforsale
9456000
CY2023Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
7999000
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
8228000
CY2023Q1 us-gaap Interest Receivable
InterestReceivable
5162000
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
5696000
CY2023Q1 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
179816000
CY2022Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
166061000
CY2023Q1 ohi Inducements To Lease
InducementsToLease
5864000
CY2022Q4 ohi Inducements To Lease
InducementsToLease
6041000
CY2023Q1 us-gaap Other Receivables
OtherReceivables
190842000
CY2022Q4 us-gaap Other Receivables
OtherReceivables
177798000
CY2023Q1 ohi Number Of Operators Placed On Cash Basis
NumberOfOperatorsPlacedOnCashBasis
0
CY2022Q1 ohi Number Of Operators Placed On Cash Basis
NumberOfOperatorsPlacedOnCashBasis
2
CY2023Q1 ohi Number Of Operators In Which Deferred Rent Was Allowed
NumberOfOperatorsInWhichDeferredRentWasAllowed
8
CY2022Q1 ohi Number Of Operators In Which Deferred Rent Was Allowed
NumberOfOperatorsInWhichDeferredRentWasAllowed
6
CY2023Q1 ohi Deferred Aggregate Rent
DeferredAggregateRent
24400000
CY2022Q1 ohi Deferred Aggregate Rent
DeferredAggregateRent
19300000
CY2023Q1 ohi Number Of Operators In Which Security Deposit Was Applied To Pay Rent
NumberOfOperatorsInWhichSecurityDepositWasAppliedToPayRent
3
CY2022Q1 ohi Number Of Operators In Which Security Deposit Was Applied To Pay Rent
NumberOfOperatorsInWhichSecurityDepositWasAppliedToPayRent
4
CY2023Q1 ohi Security Deposit Amount Used Against Uncollectible Receivables
SecurityDepositAmountUsedAgainstUncollectibleReceivables
5200000
CY2022Q1 ohi Security Deposit Amount Used Against Uncollectible Receivables
SecurityDepositAmountUsedAgainstUncollectibleReceivables
3300000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
1061869000
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
1042731000
CY2022Q4 us-gaap Direct Financing Lease Net Investment In Lease Allowance For Credit Loss Excluding Accrued Interest
DirectFinancingLeaseNetInvestmentInLeaseAllowanceForCreditLossExcludingAccruedInterest
2816000
CY2023Q1 us-gaap Direct Financing Lease Impairment Loss
DirectFinancingLeaseImpairmentLoss
-193000
CY2023Q1 us-gaap Direct Financing Lease Net Investment In Lease Allowance For Credit Loss Excluding Accrued Interest
DirectFinancingLeaseNetInvestmentInLeaseAllowanceForCreditLossExcludingAccruedInterest
2623000
CY2022Q4 ohi Total Receivable Allowance For Credit Loss
TotalReceivableAllowanceForCreditLoss
188364000
CY2023Q1 ohi Total Receivable Credit Loss Expense Reversal
TotalReceivableCreditLossExpenseReversal
-4057000
CY2023Q1 ohi Total Receivable Allowance For Credit Loss
TotalReceivableAllowanceForCreditLoss
209507000
CY2021Q4 us-gaap Direct Financing Lease Net Investment In Lease Allowance For Credit Loss Excluding Accrued Interest
DirectFinancingLeaseNetInvestmentInLeaseAllowanceForCreditLossExcludingAccruedInterest
530000
CY2022Q1 us-gaap Direct Financing Lease Impairment Loss
DirectFinancingLeaseImpairmentLoss
5000
CY2022Q1 us-gaap Direct Financing Lease Net Investment In Lease Allowance For Credit Loss Excluding Accrued Interest
DirectFinancingLeaseNetInvestmentInLeaseAllowanceForCreditLossExcludingAccruedInterest
535000
CY2021Q4 ohi Total Receivable Allowance For Credit Loss
TotalReceivableAllowanceForCreditLoss
144466000
CY2022Q1 ohi Total Receivable Credit Loss Expense Reversal
TotalReceivableCreditLossExpenseReversal
1824000
CY2022Q1 ohi Total Receivable Allowance For Credit Loss
TotalReceivableAllowanceForCreditLoss
146290000
CY2023Q1 ohi Direct Financing Lease Net Investment In Lease Originated Six Or More Years Before Latest Fiscal Year
DirectFinancingLeaseNetInvestmentInLeaseOriginatedSixOrMoreYearsBeforeLatestFiscalYear
11293000
CY2023Q1 us-gaap Direct Financing Lease Net Investment In Lease Excluding Accrued Interest Before Allowance For Credit Loss
DirectFinancingLeaseNetInvestmentInLeaseExcludingAccruedInterestBeforeAllowanceForCreditLoss
11293000
CY2023Q1 ohi Total Receivable Year One Originated Current Fiscal Year
TotalReceivableYearOneOriginatedCurrentFiscalYear
13633000
CY2023Q1 ohi Total Receivable Year Two Originated Fiscal Year Before Current Fiscal Year
TotalReceivableYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
103470000
CY2023Q1 ohi Total Receivable Year Three Originated Two Years Before Current Fiscal Year
TotalReceivableYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
110579000
CY2023Q1 ohi Total Receivable Year Four Originated Three Years Before Current Fiscal Year
TotalReceivableYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
110837000
CY2023Q1 ohi Total Receivable Year Five Originated Four Years Before Current Fiscal Year
TotalReceivableYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
13668000
CY2023Q1 ohi Total Receivable Originated Five Years Before Latest Fiscal Year
TotalReceivableOriginatedFiveYearsBeforeLatestFiscalYear
194311000
CY2023Q1 ohi Total Receivable Originated Six Or More Years Before Latest Fiscal Year
TotalReceivableOriginatedSixOrMoreYearsBeforeLatestFiscalYear
527818000
CY2023Q1 ohi Total Receivable Revolving
TotalReceivableRevolving
392731000
CY2023Q1 ohi Total Receivable Before Allowance For Credit Loss Total
TotalReceivableBeforeAllowanceForCreditLossTotal
1467047000
CY2023Q1 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
8000000.0
CY2022Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
8200000
CY2023Q1 us-gaap Interest Receivable
InterestReceivable
5200000
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
5700000
CY2023Q1 us-gaap Financing Receivable Nonaccrual Interest Income
FinancingReceivableNonaccrualInterestIncome
1500000
CY2022Q1 us-gaap Financing Receivable Nonaccrual Interest Income
FinancingReceivableNonaccrualInterestIncome
4200000
CY2023Q1 ohi Initial Investment Equity Method Investment
InitialInvestmentEquityMethodInvestment
230567000
CY2023Q1 us-gaap Equity Method Investments
EquityMethodInvestments
181339000
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
178920000
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
831000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1623000
CY2022Q1 us-gaap Property Management Fee Revenue
PropertyManagementFeeRevenue
200000
CY2023Q1 us-gaap Property Management Fee Revenue
PropertyManagementFeeRevenue
200000
CY2022Q4 us-gaap Goodwill
Goodwill
643151000
CY2023Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
349000
CY2023Q1 us-gaap Goodwill
Goodwill
643500000
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5929000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5929000
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4520000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4484000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1409000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1445000
CY2023Q1 us-gaap Below Market Lease Gross
BelowMarketLeaseGross
55183000
CY2022Q4 us-gaap Below Market Lease Gross
BelowMarketLeaseGross
66433000
CY2023Q1 us-gaap Below Market Lease Accumulated Amortization
BelowMarketLeaseAccumulatedAmortization
39512000
CY2022Q4 us-gaap Below Market Lease Accumulated Amortization
BelowMarketLeaseAccumulatedAmortization
44595000
CY2023Q1 us-gaap Below Market Lease Net
BelowMarketLeaseNet
15671000
CY2022Q4 us-gaap Below Market Lease Net
BelowMarketLeaseNet
21838000
CY2023Q1 ohi Net Amortization Of Intangible Assets
NetAmortizationOfIntangibleAssets
6100000
CY2022Q1 ohi Net Amortization Of Intangible Assets
NetAmortizationOfIntangibleAssets
1600000
CY2023Q1 ohi Finite Lived Intangible Assets Net Amortization Income Remaining Current Year
FiniteLivedIntangibleAssetsNetAmortizationIncomeRemainingCurrentYear
2000000.0
CY2023Q1 ohi Finite Lived Intangible Assets Net Amortization Income Next Twelve Months
FiniteLivedIntangibleAssetsNetAmortizationIncomeNextTwelveMonths
2500000
CY2023Q1 ohi Finite Lived Intangible Assets Net Amortization Income Year Two
FiniteLivedIntangibleAssetsNetAmortizationIncomeYearTwo
2500000
CY2023Q1 ohi Finite Lived Intangible Assets Net Amortization Income Year Three
FiniteLivedIntangibleAssetsNetAmortizationIncomeYearThree
2000000.0
CY2023Q1 ohi Finite Lived Intangible Assets Net Amortization Income Year Four
FiniteLivedIntangibleAssetsNetAmortizationIncomeYearFour
1700000
CY2023Q1 ohi Below Market Lease Weighted Average Remaining Amortization Period
BelowMarketLeaseWeightedAverageRemainingAmortizationPeriod
P7Y
CY2022Q4 us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
30750000
CY2022Q3 us-gaap Loss Contingency Accrual Carrying Value Period Increase Decrease
LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
31000000
CY2022Q3 us-gaap Increase Decrease In Insurance Settlements Receivable
IncreaseDecreaseInInsuranceSettlementsReceivable
31000000
CY2023Q1 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
931
CY2023Q1 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
42
CY2023Q1 ohi Number Of Operators
NumberOfOperators
68
CY2023Q1 ohi Gross Investment In Facilities Net Of Impairments And Reserve For Uncollectible Loans
GrossInvestmentInFacilitiesNetOfImpairmentsAndReserveForUncollectibleLoans
9500000000
CY2023Q1 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
189900000
CY2023Q1 us-gaap Equity Method Investments
EquityMethodInvestments
181300000
CY2023Q1 ohi Number Of Unconsolidated Joint Ventures
NumberOfUnconsolidatedJointVentures
5
CY2023Q1 ohi Number Of Operators That Met Or Exceeded Ten Percent Of Investments
NumberOfOperatorsThatMetOrExceededTenPercentOfInvestments
1
CY2022Q4 ohi Number Of Operators That Met Or Exceeded Ten Percent Of Investments
NumberOfOperatorsThatMetOrExceededTenPercentOfInvestments
1
CY2022Q4 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2023-02-06
CY2022Q4 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2023-02-15
CY2022Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.67
CY2023Q1 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2023-05-01
CY2023Q1 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2023-05-15
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.67
CY2023Q1 ohi Percentage Of Income Taxable
PercentageOfIncomeTaxable
1
CY2023Q1 ohi Number Of Taxable Reit Subsidiaries Subject To Federal And State And Local Income Taxes With Net Operating Loss Carryforwards
NumberOfTaxableReitSubsidiariesSubjectToFederalAndStateAndLocalIncomeTaxesWithNetOperatingLossCarryforwards
1
CY2023Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2138000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2138000
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2138000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2138000
CY2023Q1 us-gaap Deferred Tax Assets Tax Credit Carryforwards Foreign
DeferredTaxAssetsTaxCreditCarryforwardsForeign
10782000
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Foreign
DeferredTaxAssetsTaxCreditCarryforwardsForeign
11268000
CY2023Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
10782000
CY2023Q1 ohi Current And Deferred Federal State And Local Income Tax Expense Benefit
CurrentAndDeferredFederalStateAndLocalIncomeTaxExpenseBenefit
300000
CY2022Q1 ohi Current And Deferred Federal State And Local Income Tax Expense Benefit
CurrentAndDeferredFederalStateAndLocalIncomeTaxExpenseBenefit
300000
CY2023Q1 us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
-1600000
CY2022Q1 us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
900000
CY2023Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-1300000
CY2022Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1200000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8700000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6900000
CY2023Q1 us-gaap Line Of Credit
LineOfCredit
19784000
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
19246000
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
5287934000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
5286834000
CY2023Q1 us-gaap Debt Instrument Covenant Compliance
DebtInstrumentCovenantCompliance
As of March 31, 2023 and December 31, 2022, we were in compliance with all applicable covenants for our borrowings
CY2022 us-gaap Debt Instrument Covenant Compliance
DebtInstrumentCovenantCompliance
As of March 31, 2023 and December 31, 2022, we were in compliance with all applicable covenants for our borrowings
CY2023Q1 us-gaap Contractual Obligation
ContractualObligation
381920000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
35942000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
189607000
CY2023Q1 ohi Net Income Loss Attributable To Op Units
NetIncomeLossAttributableToOpUnits
1048000
CY2022Q1 ohi Net Income Loss Attributable To Op Units
NetIncomeLossAttributableToOpUnits
5549000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
36990000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
195156000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
234954000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
239527000
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1384000
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
963000
CY2023Q1 ohi Noncontrolling Interest Operating Partnership Units
NoncontrollingInterestOperatingPartnershipUnits
6850000
CY2022Q1 ohi Noncontrolling Interest Operating Partnership Units
NoncontrollingInterestOperatingPartnershipUnits
7066000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
243188000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
247556000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.79
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.79
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
245182000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
491247000
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3336000
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3534000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
248518000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
494781000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
61451000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
60478000
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1636000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1716000
CY2022Q1 ohi Noncash Acquisition Of Real Estate
NoncashAcquisitionOfRealEstate
11133000
CY2022Q1 ohi Non Cash Contribution From Non Controlling Interest To Consolidated Joint Venture
NonCashContributionFromNonControllingInterestToConsolidatedJointVenture
2903000
CY2023Q1 ohi Change In Fair Value Of Cash Flow Hedges
ChangeInFairValueOfCashFlowHedges
-13516000
CY2022Q1 ohi Change In Fair Value Of Cash Flow Hedges
ChangeInFairValueOfCashFlowHedges
24489000
CY2023Q1 ohi Remeasurement Of Debt Denominated Foreign Currency
RemeasurementOfDebtDenominatedForeignCurrency
538000
CY2022Q1 ohi Remeasurement Of Debt Denominated Foreign Currency
RemeasurementOfDebtDenominatedForeignCurrency
-320000

Files In Submission

Name View Source Status
0000888491-23-000015-index-headers.html Edgar Link pending
0000888491-23-000015-index.html Edgar Link pending
0000888491-23-000015.txt Edgar Link pending
0000888491-23-000015-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ohi-20230331.xsd Edgar Link pending
ohi-20230331x10q.htm Edgar Link pending
ohi-20230331xex31d1.htm Edgar Link pending
ohi-20230331xex31d2.htm Edgar Link pending
ohi-20230331xex32d1.htm Edgar Link pending
ohi-20230331xex32d2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
ohi-20230331_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ohi-20230331x10q_htm.xml Edgar Link completed
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ohi-20230331_lab.xml Edgar Link unprocessable
ohi-20230331_cal.xml Edgar Link unprocessable
ohi-20230331_pre.xml Edgar Link unprocessable